Navigation Links
Essilor - First-Half 2008 Revenue
Date:7/16/2008

anges in the scope of consolidation, 2.9% came from acquisitions made in 2007, led by OOGP, KBco and ILT. Consolidation of companies acquired since the beginning of 2008 (except Satisloh) added 1.3 point of external growth.

As in the first quarter, the currency effect, which totalled a negative 6.6% over the half, was primarily due to the fall in the US dollar against the euro (down 13.7% over the period) and to a lesser extent to the decline in the British pound (down 13.4% against the euro). The 3.2% slide in the Canadian dollar and the sharp 18.7% drop in the Korean won, both against the euro, also weighed on reported revenue for the half.

Revenue by region

In Europe, growth was dampened both by an unfavorable comparison with first-half 2007, when revenue rose 8.4% on the launch of Varilux Physio(R) and Anateo(R), and by the generally weaker economy. A strong performance in Germany and the Netherlands contrasted with slower growth in the United Kingdom, Spain and Italy, while positions were maintained in France.

In the United States, the slowdown at certain optical chains was offset by robust growth at independent eyecare professionals, among whom the Company continued to widen its market share. This enabled Essilor of America to report 7.4% like-for-like growth for the half. Business was also satisfactory in Canada.

Performance varied by country in the Asia-Pacific region, with growth remaining very strong in the ASEAN countries, India and South Korea, but slowing in China in the second quarter. After a particularly difficult beginning of the year, business in Australia and New Zealand is starting to recover, especially in the independent eyecare professionals segment. In Japan, Essilor is continuing to gain market share from the competition in a flat market.

All of the country organizations in Latin America reported excellent results for the period, despite the very high prior-year comparatives. Operations in Argentina
'/>"/>

SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
2. Essilor Acquires Prescription Laboratories in the United Kingdom and the United States
3. Essilor Enters Bulgarian Market
4. Essilor : 2007 Results
5. Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States
6. Essilors 2008 First-Quarter Report
7. Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions
8. Marlabs in the Top 10 BPO Healthcare Revenue Cycle Management Companies
9. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
10. Memry Corporation FY 2007 Revenues $51.7M; Net Income $317,000 or $0.01 Per Share
11. QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Reportlinker.com announces that a new ... catalogue: ,, http://www.reportlinker.com/p0169956/Top-Ten-Worlds-Leading-Animal-Health-Companies.html ,, ... animal health industry executives with strategically significant ... the development and implementation of effective marketing ... include: ,, To establish a ...
(Date:12/17/2009)... following feature is by Devon Herrick, PhD, Senior Fellow ... People often assume they have little control over how ... sickness cannot be scheduled, doctors prescribe treatments and employers ... Americans. However, there are many overlooked ways to trim ... need. ,, Cut your prescription costs: ...
(Date:12/17/2009)... WASHINGTON, Dec. 17 The National Council ... meeting at the JW Marriott Houston, 5150 Westheimer, Houston, ... 2010, and ending at 11:00 a.m. on Thursday, January ... ,, NCD believes it is vital to hear ... what does not for people with disabilities. This meeting ...
(Date:12/17/2009)... MA Brandeis University selected Jay and Maureen Neitz, the ... use of gene therapy to treat vision disorders, as ... in Vision Sciences. , The award is funded by ... gift from Brandeis graduates Jay Pepose ,75 and Susan ... graduate research fellowships in vision science. , The Neitzes, ...
(Date:12/17/2009)... lung infections , , THURSDAY, Dec. 17 (HealthDay News) -- ... swine flu virus, and researchers say they,ve found a ... severity of the illness appears to be a molecule ... fight off germs and disease. Researchers who analyzed levels ... hospitals last summer found the highest levels in the ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 3Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 4Health News:Six Ways to Slash Your Health Costs 2Health News:Six Ways to Slash Your Health Costs 3Health News:Six Ways to Slash Your Health Costs 4Health News:National Council on Disability to Hold Houston Meeting to Hear Issues Affecting People With Disabilities 2Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2
... carried out simultaneous raids on some government hospital doctors ... on Monday.// ,The raids were conducted in Chennai, ... of the investigating agency said., ,The houses of ... Uma Goel of Sucheta Kriplani Hospital here were searched, ...
... live mutated viruses can cure tumors in animals and humans.,Scientists ... a patient with an aggressive //form of brain cancer after ... ,A mutation of the herpes virus was injected into ... live in 1997. But, eight years later he is still ...
... Apollo Hospitals Group plans to invest Rs 350 crore to ... planned new addition of 1800 beds, Apollo Group's total capacity ... ,"There is a plan for adding 800 beds through ... Apollo Hospitals Group Director Finance, Suneeta Reddy, said here on ...
... lead to a multitude of complications if left untreated. ... possibility of using tea as a form of treatment ... found to prevent the incidence of cataracts, a significant ... , ,Researchers developed special rats with diabetes. This ...
... cases in India is probably much higher than official data ... ,India, which has 5.1 million people with AIDS or ... in 2005 that new infections had sharply fallen to 28,000 ... aid groups have expressed skepticism about those figures. Peter ...
... exercise capacity and functional ability in patients with pulmonary ... the blood vessels that enter the lungs, a new ... the findings, which appear in The New England Journal ... patients who were randomly selected to receive Viagra, at ...
Other Medicine News:
(Date:12/16/2009)... -- Accuray Incorporated (Nasdaq: ARAY ), a global ... its president and chief executive officer, Euan S. Thomson, ... J.P. Morgan Healthcare Conference in San Francisco on Wednesday, ... ,, A live webcast of each presentation will ... the Company,s Web site at http://www.accuray.com . ...
(Date:12/16/2009)... Dec. 16 A new ... manage the clinical review of specialty pharmaceuticals has ... of drugs reviewed while reducing costs. ,, AIM, ... company with health plan clients representing over 35 ... Inc. (NYSE: WLP ), adapted the ...
(Date:12/16/2009)... December 16 Scientists at,deCODE genetics, Inc. ... the,discovery of a version of a common single-letter ... with a major impact on susceptibility to type ... is not only large, but unusual:,if an individual ... risk of,T2D by more than 30% compared to ...
Breaking Medicine Technology:Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4Engineered pig stem cells bridge the mouse human gap 8715 1Ganeden Biotech Liquid Health Labs Unveil New Drink Technology 12471 1Ganeden Biotech Liquid Health Labs Unveil New Drink Technology 12471 2Ganeden Biotech Liquid Health Labs Unveil New Drink Technology 12471 3Best Practices for Hospitals Moving to Electronic Medical Records 47908 1Best Practices for Hospitals Moving to Electronic Medical Records 47908 2
... Sept. 4 Quark Pharmaceuticals, Inc., a,clinical-stage biopharmaceutical ... therapeutics, announced today that,J. Joseph Marr, M.D. has ... In this capacity, Dr. Marr will play ... and in outlining the goals and plans of ...
... whole range ... Phase II, III and IV Clinical Trials, WAYLAND, ... off-the-shelf and custom supply chain software for the,biopharmaceutical, retail, ... tcVisualize(TM) 3.0 clinical trial supply simulator. The,latest generation tcVisualize ...
Other Medicine Technology:Quark Pharmaceuticals Appoints New Chief Medical Officer 2Quark Pharmaceuticals Appoints New Chief Medical Officer 3Quark Pharmaceuticals Appoints New Chief Medical Officer 4Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator 2
... suction catheters are available ... , ,All Portex® ... are latex-free., ,Maxi-Flo® ... catheter tip design which ...
... packaged in order of use ... of multi-compartment trays allows flexibility, ... waste by providing exact quantities ... or non-sterile. Stackable container for ...
Suction Catheter Mini Soft Kits without Solutions...
Suction Catheter Kits with Sterile Saline (Bottle)...
Medicine Products: